Retatrutide
Retatrutide for laboratory research. Batch-level documentation with CoA. Research use only — not for human use. Retatrutide, referred to in the research literature as LY3437943, is a 39-amino-acid synthetic peptide that engages three receptors central to metabolism simultaneously. It was designed by researchers at Eli Lilly as the first of its kind: a single molecule that activates the GLP-1, GIP and glucagon receptors at the same time. This threefold engagement makes it a widely studied compound in research on energy and glucose regulation.
Peptalis — for laboratory research use only. Not for human use.